Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $447.94 million. The enterprise value is $437.85 million.

Market Cap	447.94M
Enterprise Value	437.85M

Important Dates

The last earnings date was Tuesday, August 5, 2025, after market close.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 227.38 million shares outstanding. The number of shares has increased by 4.01% in one year.

Current Share Class	227.38M
Shares Outstanding	227.38M
Shares Change (YoY)	+4.01%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	64.97%
Float	183.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.10
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	10.88
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.40

Current Ratio	4.40
Quick Ratio	4.11
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-13.28

Financial Efficiency

Return on equity (ROE) is -783.37% and return on invested capital (ROIC) is -41.64%.

Return on Equity (ROE)	-783.37%
Return on Assets (ROA)	-29.63%
Return on Invested Capital (ROIC)	-41.64%
Return on Capital Employed (ROCE)	-77.74%
Revenue Per Employee	$277,497
Profits Per Employee	-$956,848
Employee Count	145
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	-3.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +147.80% in the last 52 weeks. The beta is 1.96, so Gossamer Bio's price volatility has been higher than the market average.

Beta (5Y)	1.96
52-Week Price Change	+147.80%
50-Day Moving Average	1.55
200-Day Moving Average	1.14
Relative Strength Index (RSI)	58.89
Average Volume (20 Days)	3,489,808

Short Selling Information

The latest short interest is 18.75 million, so 8.24% of the outstanding shares have been sold short.

Short Interest	18.75M
Short Previous Month	18.12M
Short % of Shares Out	8.24%
Short % of Float	10.20%
Short Ratio (days to cover)	7.01

Income Statement

In the last 12 months, Gossamer Bio had revenue of $40.24 million and -$138.74 million in losses. Loss per share was -$0.61.

Revenue	40.24M
Gross Profit	40.24M
Operating Income	-145.62M
Pretax Income	-172.58M
Net Income	-138.74M
EBITDA	-145.29M
EBIT	-145.62M
Loss Per Share	-$0.61

Full Income Statement

Balance Sheet

The company has $212.92 million in cash and $202.83 million in debt, giving a net cash position of $10.09 million or $0.04 per share.

Cash & Cash Equivalents	212.92M
Total Debt	202.83M
Net Cash	10.09M
Net Cash Per Share	$0.04
Equity (Book Value)	-46.11M
Book Value Per Share	-0.20
Working Capital	182.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$154.30 million and capital expenditures -$79,000, giving a free cash flow of -$154.38 million.

Operating Cash Flow	-154.30M
Capital Expenditures	-79,000
Free Cash Flow	-154.38M
FCF Per Share	-$0.68

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-361.91%
Pretax Margin	-353.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.01%
Shareholder Yield	-4.01%
Earnings Yield	-30.97%
FCF Yield	-34.46%

Analyst Forecast

The average price target for Gossamer Bio is $8.50, which is 331.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.50
Price Target Difference	331.47%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	25.76%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -8.25. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.25
Piotroski F-Score	n/a